Back to mobile site

Johnson & Johnson (JNJ) PT Raised to $142 at Stifel on 3Q Earnings Report; 'Pharma Carries the Day, Hurricane Headwinds Encouragingly Modest

October 17, 2017 5:16 PM EDT Send to a Friend
Stifel raised its price target on Johnson & Johnson (NYSE: JNJ) to $142.00 (from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login